Brugada syndrome-like ST-segment elevation increase exacerbated by vomiting

被引:5
作者
Arai, M [1 ]
Nakazawa, K [1 ]
Takagi, A [1 ]
Kishi, R [1 ]
Osada, K [1 ]
Ryu, S [1 ]
Miyake, F [1 ]
机构
[1] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan
关键词
Brugada syndrome; pilsicainide; ST-segment; vagal activity; vomiting;
D O I
10.1253/circj.68.712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The patient was a 53 year-old male who had 3 syncopal episodes over a 6-month period. In the electrophysiological study, ventricular fibrillation (VF) was repeatedly induced by the ventricular extrastimulus method. Intravenous pilsicainide was administered, and the J-point and ST-segment in the right precordial leads became slightly elevated just following drug administration. Five min later, the patient experienced severe nausea and then vomited twice, at which point the electrocardiogram (ECG) showed increased elevation of the J-point and ST-segment. These ECG changes recovered to normal 30 min later. The cause of his syncope was strongly suspected to be related to the VF associated with Brugada syndrome. An interesting aspect of this case was the particular type of J-point and ST-segment elevation that was induced when the patient experienced nausea and vomiting. It is proposed that this phenomenon originated from the vagal stimulation associated with the nausea and vomiting.
引用
收藏
页码:712 / 714
页数:3
相关论文
共 8 条
  • [1] RIGHT BUNDLE-BRANCH BLOCK, PERSISTENT ST SEGMENT ELEVATION AND SUDDEN CARDIAC DEATH - A DISTINCT CLINICAL AND ELECTROCARDIOGRAPHIC SYNDROME - A MULTICENTER REPORT
    BRUGADA, P
    BRUGADA, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (06) : 1391 - 1396
  • [2] Genetic basis and molecular mechanism for idiopathic: ventricular fibrillation
    Chen, QY
    Kirsch, GE
    Zhang, DM
    Brugada, R
    Brugada, J
    Brugada, P
    Potenza, D
    Moya, A
    Borggrefe, M
    Breithardt, G
    Ortiz-Lopez, R
    Wang, Z
    Antzelevitch, C
    O'Brien, RE
    Schulze-Bahr, E
    Keating, MT
    Towbin, JA
    Wang, Q
    [J]. NATURE, 1998, 392 (6673) : 293 - 296
  • [3] The Brugada syndrome: Clinical, electrophysiologic and genetic aspects
    Gussak, I
    Antzelevitch, C
    Bjerregaard, P
    Towbin, JA
    Chaitman, BR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) : 5 - 15
  • [4] Arrhythmias in patients with Brugada-type electrocardiographic findings
    Itoh, H
    Shimizu, M
    Ino, H
    Okeie, K
    Yamaguchi, M
    Fujino, N
    Mabuchi, H
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (06): : 483 - 486
  • [5] Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease
    Kasanuki, H
    Ohnishi, S
    Ohtuka, M
    Matsuda, N
    Nirei, T
    Isogai, R
    Shoda, M
    Toyoshima, Y
    Hosoda, S
    [J]. CIRCULATION, 1997, 95 (09) : 2277 - 2285
  • [6] Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome
    Miyazaki, T
    Mitamura, H
    Miyoshi, S
    Soejima, K
    Aizawa, Y
    Ogawa, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (05) : 1061 - 1070
  • [7] NAKAZAWA K, 2000, ST MARIANNA MED J, V28, P247
  • [8] Clinical significance of the dispersion of the activation-recovery interval and recovery time as markers for ventricular fibrillation susceptibility in patients with Brugada syndrome
    Nanke, T
    Nakazawa, K
    Arai, M
    Ryuu, S
    Osada, K
    Sakurai, T
    Miyake, F
    [J]. CIRCULATION JOURNAL, 2002, 66 (06) : 549 - 552